2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of patient visits, regardless of patient age, withContinue reading “2024 MIPS Measure #143: Oncology: Medical and Radiation – Pain Intensity Quantified”
eCQM Archive
2024 MIPS Measure #1: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Intermediate Outcome – High Priority Description Percentage of patients 18-75 years of age withContinue reading “2024 MIPS Measure #1: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)”
2024 MIPS Measure #5: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #5: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2024 MIPS Measure #7: Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #7: Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)”
2024 MIPS Measure #8: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #8: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2024 MIPS Measure #19: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of patients aged 18 years and older withContinue reading “2024 MIPS Measure #19: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care”
2024 MIPS Measure #65: Appropriate Treatment for Upper Respiratory Infection (URI)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of episodes for patients 3 months of ageContinue reading “2024 MIPS Measure #65: Appropriate Treatment for Upper Respiratory Infection (URI)”
2024 MIPS Measure #66: Appropriate Testing for Pharyngitis
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description The percentage of episodes for patients 3 years andContinue reading “2024 MIPS Measure #66: Appropriate Testing for Pharyngitis”
2024 MIPS Measure #102: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of patients, regardless of age, with a diagnosisContinue reading “2024 MIPS Measure #102: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients”
2024 MIPS Measure #112: Breast Cancer Screening
2024 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) – MIPS VALUE PATHWAYS (MVP) REPORTING ONLY MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process DescriptionContinue reading “2024 MIPS Measure #112: Breast Cancer Screening”